Baillie Gifford & Co
ASND icon

Baillie Gifford & Co’s Ascendis Pharma A/S ASND Stock Holding History

Baillie Gifford & Co’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-21,403
Closed -$3.2M – 273
2024
Q3 		$3.2M Sell
21,403
-49,668
-70% -$6.71M ﹤0.01% 237
2024
Q2 		$9.69M Sell
71,071
-10,135
-12% -$1.38M 0.01% 216
2024
Q1 		$12.3M Sell
81,206
-464
-0.6% -$66.2K 0.01% 217
2023
Q4 		$10.3M Sell
81,670
-4,651
-5% -$464K 0.01% 222
2023
Q3 		$8.08M Sell
86,321
-4,181
-5% -$391K 0.01% 222
2023
Q2 		$8.08M Sell
90,502
-1,191
-1% -$104K 0.01% 226
2023
Q1 		$9.83M Buy
91,693
+11
+0% +$1.26K 0.01% 222
2022
Q4 		$11.2M Buy
91,682
+3,185
+4% +$370K 0.01% 212
2022
Q3 		$9.14M Buy
88,497
+2,697
+3% +$256K 0.01% 218
2022
Q2 		$7.98M Sell
85,800
-8,851
-9% -$834K 0.01% 220
2022
Q1 		$11.1M Buy
94,651
+8,579
+10% +$994K 0.01% 232
2021
Q4 		$11.6M Buy
86,072
+2,638
+3% +$392K 0.01% 242
2021
Q3 		$13.3M Buy
83,434
+8,882
+12% +$1.22M 0.01% 237
2021
Q2 		$9.81M Sell
74,552
-27,742
-27% -$3.7M ﹤0.01% 247
2021
Q1 		$13.2M Buy
102,294
+55,139
+117% +$8.38M 0.01% 234
2020
Q4 		$7.87M Buy
+47,155
New +$7.8M ﹤0.01% 227

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Baillie Gifford & Co's ASND Position: Q4 2024 in Review

Baillie Gifford & Co sold out of Ascendis Pharma A/S (ASND) in Q4 2024, closing a stake of 21,403 shares — an estimated $3.2M sold.

Baillie Gifford & Co first reported a position in ASND in Q4 2020 and held it in 16 quarters. The position peaked at $13.3M in Q3 2021. 214 funds tracked by Wall St. Rank hold ASND as of Q4 2024.

  • Baillie Gifford & Co reported no remaining Ascendis Pharma A/S position as of Q4 2024 after selling out during the quarter.
  • Baillie Gifford & Co sold 21,403 Ascendis Pharma A/S shares in Q4 2024, an estimated $3.2M.
  • Baillie Gifford & Co first reported a position in Ascendis Pharma A/S in Q4 2020 and held it in 16 quarters.
  • Baillie Gifford & Co's Ascendis Pharma A/S position peaked at $13.3M in Q3 2021.
  • 214 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q4 2024.

Based on Baillie Gifford & Co's 13F filing for Q4 2024, filed 31 Jan 2025.